• Xenon Pharmaceuticals' (XENE) "Outperform" Rating Reaffirmed at William Blair

    المصدر: Buzz FX / 01 مارس 2025 13:21:13   America/New_York


    Xenon Pharmaceuticals' (XENE) "Outperform" Rating Reaffirmed at William Blair Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Xenon Pharmaceuticals ( NASDAQ:XENE - Get Free Report ) 's stock had its "outperform" rating r
    Read more...
شارك على،